Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research.
Among the large range of organs involved in the field of tissue engineering (skin, blood vessels, cartilage, etc.) the liver has been given broad attention in the last decade. Liver support systems encompassing artificial and bioartificial systems are applied to treat patients with fulminant hepatic failure (FHF) as a bridge to orthotopic liver transplantation or to liver regeneration. To test safety, technical applicability and therapeutic effect of liver support systems, reliable animal models are needed. Due to the complexity of FHF many diverse attempts have been made to develop an adequate animal model to study liver failure, liver regeneration and liver support systems. In this paper an overview is given of the different models and their advantages and disadvantages are discussed. Suggestions are made for the most suitable large animal model to test liver support systems.
van de Kerkhove
M-P
MP
Surgical Laboratory IWO-1-172, Department of Surgery, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. m.p.vandekerkhove@amc.uva.nl
Hoekstra
R
R
van Gulik
T M
TM
Chamuleau
R A F M
RA
D000082:Acetaminophen; D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D005688:Galactosamine; D017408:Guidelines as Topic; D006498:Hepatectomy / Q000009:adverse effects*; D008099:Liver / Q000601:surgery; D017093:Liver Failure / Q000209:etiology* / Q000601:surgery*; D019164:Liver, Artificial; D012107:Research Design; D013552:Swine; D023822:Tissue Engineering / Q000379:methods*
D000082:Acetaminophen; D005688:Galactosamine